Banmeet Anand
Corporate Officer/Principal chez HARPOON THERAPEUTICS, INC.
Postes actifs de Banmeet Anand
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| HARPOON THERAPEUTICS, INC. | Corporate Officer/Principal | 06/07/2022 | - |
Historique de carrière de Banmeet Anand
Anciens postes connus de Banmeet Anand
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MOLECULAR TEMPLATES, INC. | Corporate Officer/Principal | - | - |
Formation de Banmeet Anand
| University of Missouri | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MOLECULAR TEMPLATES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- Banmeet Anand
- Expérience
